Cargando…
Subetta increases phosphorylation of insulin receptor β-subunit alone and in the presence of insulin
It has been previously shown that Subetta (a drug containing released-active forms of antibodies to the insulin receptor β-subunit and antibodies to endothelial nitric oxide synthase) stimulated insulin-induced adiponectin production by mature human adipocytes in the absence of insulin. Therefore, i...
Autores principales: | Gorbunov, E A, Nicoll, J, Kachaeva, E V, Tarasov, S A, Epstein, O I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521175/ https://www.ncbi.nlm.nih.gov/pubmed/26148148 http://dx.doi.org/10.1038/nutd.2015.20 |
Ejemplares similares
-
Subetta Treatment Increases Adiponectin Secretion by Mature Human Adipocytes In Vitro
por: Nicoll, Jim, et al.
Publicado: (2013) -
The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone
por: Bailbé, Danielle, et al.
Publicado: (2013) -
Expression of Concern on “Subetta Treatment Increases Adiponectin Secretion by Mature Human Adipocytes In Vitro”
Publicado: (2019) -
In vitro screening of major neurotransmitter systems possibly involved in the mechanism of action of antibodies to S100 protein in released-active form
por: Gorbunov, Evgeniy A, et al.
Publicado: (2015) -
A New Approach to Overcome Insulin Resistance in Patients with Impaired Glucose Tolerance: The Results of a Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Efficacy and Safety of Subetta
por: Mkrtumyan, Ashot, et al.
Publicado: (2022)